WINNERS & LOSERS: Eleco buyout; boohoo jumps on Primark site deal
10th Sep 2026 10:43
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More
| Price | 475.00p on 28-09-2026 at 12:55:42 |
|---|---|
| Change | 11.50p 2.48% |
| Buy | 474.00p |
| Sell | 450.00p |
| Last Trade: | Buy 51.00 at 471.95p |
| Day's Volume: | 13,538 |
| Last Close: | 463.50p |
| Open: | 475.00p |
| ISIN: | GB00BQVXM815 |
| Day's Range | 475.00p - 475.00p |
| 52wk Range: | 390.00p - 1,330.00p |
| Market Capitalisation: | £32.76m |
| VWAP: | 468.05704p |
| Shares in Issue: | 6.90m |
Sector: Medicine and Biotech
Hemogenyx Pharmaceuticals (HEMO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 51 | 471.95p | Ordinary |
13:31:08 - 28-Sep-26 |
| Buy* | 69 | 471.95p | Ordinary |
13:30:03 - 28-Sep-26 |
| Buy* | 20 | 474.00p | Ordinary |
13:00:15 - 28-Sep-26 |
| Unknown* | 0 | 450.00p | SI Trade |
12:53:59 - 28-Sep-26 |
| Buy* | 1 | 474.00p | SI Trade |
12:31:42 - 28-Sep-26 |
| Buy* | 1 | 474.00p | SI Trade |
12:03:59 - 28-Sep-26 |
| Buy* | 1,052 | 472.00p | Ordinary |
11:24:49 - 28-Sep-26 |
| Buy* | 32 | 472.00p | Ordinary |
10:47:39 - 28-Sep-26 |
| Buy* | 100 | 472.00p | Ordinary |
10:43:10 - 28-Sep-26 |
| Sell* | 500 | 455.03p | Ordinary |
10:21:38 - 28-Sep-26 |
Hemogenyx Pharmaceuticals (HEMO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Sep 2026 7:00 am | RNS | Exercise of Warrants and Issue of Equity |
| 11th Aug 2026 7:00 am | RNS | Collaboration with Cellin Technologies |
| 29th Jul 2026 7:00 am | RNS | Collaboration and Company Update |
| 1st Jul 2026 7:00 am | RNS | Result of AGM |
| 5th Jun 2026 7:00 am | RNS | Notice of AGM |
| 29th May 2026 9:18 am | RNS | Grant of Options and Extension of Warrant Term |
| 30th Apr 2026 4:04 pm | RNS | Final Results |
| 28th Apr 2026 7:00 am | RNS | Institutional Fundraise |
| 14th Apr 2026 7:00 am | RNS | Annual IND Report with FDA |
| 31st Mar 2026 1:22 pm | RNS | Tech Transfer Completion and Clinical Trial Update |